Ушбу иш иқтибос қилган ишлар

44 та иш

Иш: Recombinant cell-penetrating trichosanthin synergizes anti-PD-1 therapy in colorectal tumor

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel +4
МақолаGlobal Cancer Incidence and ScreeningCA A Cancer Journal for Clinicians202160 иқтибос
ABI
Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature
Yingzhi Chen, Meng Zhang, Hongyue Jin +6
Мақола20167 иқтибос
ABI
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp +2
Шарҳ мақола20165 иқтибос
ABI
Prodrug-Like, PEGylated Protein Toxin Trichosanthin for Reversal of Chemoresistance
Yingzhi Chen, Meng Zhang, Hongyue Jin +4
Мақола20175 иқтибос
ABI
Dual-targeting biomimetic delivery for anti-glioma activityviaremodeling the tumor microenvironment and directing macrophage-mediated immunotherapy
Pengfei Zhao, Yonghui Wang, Xuejia Kang +7
Мақола20184 иқтибос
ABI
Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFRT790M‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery
Weimin Yin, Xiaolu Yu, Xuejia Kang +7
Мақола20184 иқтибос
ABI
Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis
Yisi Tang, Jianming Liang, Aihua Wu +7
Мақола20174 иқтибос
ABI
Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery
Yingzhi Chen, Meng Zhang, Hongyue Jin +5
Мақола20174 иқтибос
ABI
Diagnosis and Treatment of Metastatic Colorectal Cancer
Leah H. Biller, Deborah Schrag
Шарҳ мақола20214 иқтибос
ABI
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh, Zsofia K. Stadler, Andrea Cercek +4
Шарҳ мақола20193 иқтибос
ABI
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková +7
Шарҳ мақола20203 иқтибос
ABI
Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy
Aihua Wu, Yingzhi Chen, Hairui Wang +8
Мақола20213 иқтибос
ABI
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Ben Creelan, Chao Wang, Jamie K. Teer +23
Мақола20213 иқтибос
ABI
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren +51
Шарҳ мақола20202 иқтибос
ABI
Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy
Zhidi He, Meng Zhang, Yonghui Wang +6
Мақола20202 иқтибос
ABI
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Jo Marie Tran Janco, Purushottam Lamichhane, Lavakumar Karyampudi +1
Шарҳ мақола20152 иқтибос
ABI
Dendritic Cells and Cancer Immunity
Alycia Gardner, Brian Ruffell
Шарҳ мақола20162 иқтибос
ABI
Recombinant cancer nanovaccine for targeting tumor-associated macrophage and remodeling tumor microenvironment
Yisi Tang, Wufa Fan, Guihua Chen +8
Мақола20212 иқтибос
ABI
BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFRT790M mutation
Weimin Yin, Yuge Zhao, Xuejia Kang +5
Мақола20202 иқтибос
ABI
Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery
Zening Zheng, Jiaxin Zhang, Jizong Jiang +7
Мақола20202 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI

Ушбу иш иқтибос қилган ишлар

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature

Immunogenic cell death in cancer and infectious disease

Prodrug-Like, PEGylated Protein Toxin Trichosanthin for Reversal of Chemoresistance

Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy

Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFR<sup>T790M</sup>‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery

Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis

Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery

Diagnosis and Treatment of Metastatic Colorectal Cancer

Immunotherapy in colorectal cancer: rationale, challenges and potential

Detection of immunogenic cell death and its relevance for cancer therapy

Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy

Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis

Dendritic Cells and Cancer Immunity

Recombinant cancer nanovaccine for targeting tumor-associated macrophage and remodeling tumor microenvironment

BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR<sup>T790M</sup> mutation

Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery

Сарлавҳасиз

Сарлавҳасиз

Сарлавҳасиз

Сарлавҳасиз

Сарлавҳасиз